AVSD:NYE-American Century ETF Trust - Avantis Responsible International Equity ETF (USD)

ETF | Others |

Last Closing

USD 56.7163

Change

+0.14 (+0.24)%

Market Cap

USD 0.13B

Volume

304.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

N/A

USD 65.72B
JEPI JPMorgan Equity Premium Income..

N/A

USD 33.68B
DFAC Dimensional U.S. Core Equity 2..

N/A

USD 27.49B
DTB DTB

N/A

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

N/A

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 23.09B
SGOV iShares® 0-3 Month Treasury B..

N/A

USD 20.81B
AVUV Avantis® U.S. Small Cap Value..

N/A

USD 11.25B
DFUV Dimensional US Marketwide Valu..

N/A

USD 10.54B
DFAT Dimensional U.S. Targeted Valu..

N/A

USD 9.93B

ETFs Containing AVSD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.26% 63% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.26% 59% D- 57% F
Trailing 12 Months  
Capital Gain 9.44% 49% F 54% F
Dividend Return 2.63% 47% F 38% F
Total Return 12.07% 50% F 51% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.64% 77% C+ 57% F
Dividend Return 5.12% 77% C+ 50% F
Total Return 0.48% 29% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 6.79% 65% D 87% B+
Risk Adjusted Return 75.40% 95% A 93% A
Market Capitalization 0.13B 67% D+ 28% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.